About

Bio-Light Ltd. specializes in life science technology investments and development. The Company operates a group of four subsidiary companies: OBEcure, Allergica, IOptima and Zetiq. OBEcure Ltd. is a biopharmaceutical company dedicated to development of anti-obesity drug therapies. Allergica Ltd. is a biopharmaceutical company... (more)

Buy/Sell

No analyst recommendations are available for BLLSF.PK.
» Full Recommendation

Overall

Beta: --
Market Cap (Mil.): 58.25
Shares Outstanding (Mil.): 70.09
Annual Dividend: --
Yield (%): --

Financials

  BLLSF.PK Industry Sector
P/E (TTM): -- 6.43 3.76
EPS (TTM): -129.31 -- --
ROI: -134.76 5.95 2.30
ROE: -164.02 8.98 2.82
view overview for:

Latest News about BLLSF.PK

Zetiq says test can detect cervical cancer early

JERUSALEM, May 25 (Reuters) - Israel's Zetiq, a unit of Bio-Light Ltd , said on Monday it successfully completed clinical trials for its technology for the early detection of cervical cancer.

25 May 2009

Obecure's obesity drug shows good results for women

JERUSALEM, Sept 2 (Reuters) - Israeli biopharmaceutical company Obecure said its obesity drug Histalean produced positive results for women under 50 in a recent clinical trial.

02 Sep 2007
» More BLLSF.PK News

  Earnings  vs    Estimates

No consensus analysis data available.
view overview for: